Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fully Closed-Loop Glucose Control in Adults With Type 1 Diabetes Using Tirzepatide
NCT07284511Phase 3Recruiting
- Sponsor
- McGill University Health Centre
- Start
- May 2026
- Primary completion
- Jan 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of tirzepatide in type 1 diabetes mellitus (T1D), sponsored by McGill University Health Centre. Started May 2026; status: recruiting.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07284511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284511.